交易中 09-20 10:39:49 美东时间
0.000
0.00%
Monogram Technologies (NASDAQ:MGRM) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.09) by 22.22 percent. This is a 59.26 percent increase over losses of $(0.27) per
08-15 04:47
Monogram Technologies (NASDAQ:MGRM) on Monday announced its strategic collaboration with Shalby Limited, to conduct a multicenter clinical trial to demonstrate the safety and effectiveness of the mBȏs...
08-12 21:14
Clinical Trial Collaboration Follows 510(k) Submission and Passing of FDA Admin...
08-12 20:30
Application was Submitted on July 19, 2024, Passed the FDA Administrative Revie...
08-08 20:00
Monogram Orthopaedics press release (NASDAQ:MGRM): Q1 GAAP EPS of -$0.11 in-line. Cash and cash equivalents totaled $10.1M as of March 31, 2024, compared to $13.6M as of December 31, 2023. More on Mon...
05-15 23:02
New Name Reflects Continued Evolution as an AI-Driven Robotics Company with a Strong IP Position
05-15 20:39
Monogram Orthopaedics Inc (MGRM) has issued an announcement. The Company recent...
05-14 21:32
Verification and Validation Testing Expected to be Largely Complete in Q2 2024;...
05-14 21:17
CRO Expands Clinical Capabilities, Accelerating Product Pipeline Development and Commercialization Opportunities
05-13 20:37
Gainers Monogram Orthopaedics (NASDAQ:MGRM) stock increased by 19.1% to $2.31 ...
05-06 20:06